Mastering innovation to enhance patients and caregivers quality of life.
Dianosic designs transformative intranasal solutions resolving patients adherence to medication challenges.
We collaborate with healthcare professionals in order to provide solutions that change patients’ lives in chronic rhinitis, chronic rhinosinusitis and intranasal bleeding (epistaxis).
Maximize patients quality of life, supporting a rapid return to daily life activities.
Optimize efficacy and safety through low dose, targeted drug delivery.
Reduce hospitalization time and frequency.
Leverage our intranasal drug delivery solutions to treat central nervous system diseases.
Discover our future solutions in chronic rhinitis and chronic rhinosinusitis - The Active Resorbable Intranasal Scaffold (ARIS) platform
85% of allergic rhinitis patients are not compliant with their treatment.¹ In chronic rhinitis and chronic rhinosinusitis, 20% to 25% of patients do not respond to first line treatment.²
We create solutions to provide physicians and patients with minimally invasive non-surgical solutions that will solve patient adherence to medication.
Dianosic develops a platform of cutting-edge intranasal solutions based on a proprietary know-how in drug-eluting, long-term, resorbable polymer scaffolds. Based on state of the art academic research, we collaborate with renowned physicians in order to change the treatment paradigm for debilitating diseases.
¹ Menditto E et al. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study. Clin Exp Allergy. 2019 Apr;49(4):442-460. doi: 10.1111/cea.13333.
² The Role of Balloon Sinuplasty in the Treatment of Chronic Sinusitis. Cummings JP et al. JCOM. 2009; 16(1):30-6.